[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 157,616,656
  • Shares Outstanding, K 1,741,813
  • Annual Sales, $ 44,328 M
  • Annual Income, $ 6,524 M
  • EBIT $ 9,389 M
  • EBITDA $ 12,505 M
  • 60-Month Beta 0.63
  • Price/Sales 3.56
  • Price/Cash Flow 12.95
  • Price/Book 2.99

Options Overview Details

View History
  • Implied Volatility 34.24% (+1.04%)
  • Historical Volatility 26.62%
  • IV Percentile 97%
  • IV Rank 86.56%
  • IV High 36.92% on 06/11/26
  • IV Low 16.97% on 08/12/25
  • Expected Move (DTE 1) 1.23 (1.32%)
  • Put/Call Vol Ratio 0.21
  • Today's Volume 13,591
  • Volume Avg (30-Day) 16,858
  • Put/Call OI Ratio 0.68
  • Today's Open Interest 228,579
  • Open Int (30-Day) 255,371
  • Expected Range 92.14 to 94.60

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.28
  • Number of Estimates 7
  • High Estimate $1.28
  • Low Estimate $1.27
  • Prior Year $1.26
  • Growth Rate Est. (year over year) +1.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
84.96 +9.85%
on 05/27/26
94.55 -1.30%
on 06/25/26
+5.91 (+6.77%)
since 05/22/26
3-Month
81.97 +13.85%
on 05/11/26
105.98 -11.94%
on 03/26/26
-11.51 (-10.97%)
since 03/25/26
52-Week
81.97 +13.85%
on 05/11/26
137.54 -32.15%
on 06/26/25
-44.07 (-32.08%)
since 06/25/25

Most Recent Stories

More News
Abbott hosts conference call for second-quarter earnings

ABBOTT PARK, Ill. , June 25, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its second-quarter 2026 financial results on Thursday, July 16, before the market opens.

ABT : 93.37 (+3.18%)
ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing

ALZpath Strengthens Market Leadership with Abbott Agreement to Help Enable Early Alzheimer's Diagnosis at Global Scale

ABT : 93.37 (+3.18%)
New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents

ABBOTT PARK, Ill. , June 22, 2026 /PRNewswire/ -- Parenthood is widely anticipated as one of life's most fulfilling journeys, yet for today's new parents – especially Gen Z – that excitement...

ABT : 93.37 (+3.18%)
Is STERIS Stock Underperforming the Dow?

While STERIS has underperformed relative to the Dow over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

ABT : 93.37 (+3.18%)
STE : 210.94 (+1.82%)
$DOWI : 51,928.44 (+0.15%)
Abbott declares 410th consecutive quarterly dividend

ABBOTT PARK, Ill. , June 12, 2026 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 63 cents per share.

ABT : 93.37 (+3.18%)
When Investors Finally Get Sick of AI Stocks, This Medical Devices ETF Could Be a Long-Term Winner

Over the long term, the IHI ETF looks like a good turnaround story.

ABT : 93.37 (+3.18%)
SYK : 317.24 (+1.13%)
IHI : 50.18 (+1.13%)
ISRG : 400.06 (-0.44%)
New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers

NEW ORLEANS , June 8, 2026 /PRNewswire/ -- New research presented at the American Diabetes Association's 86 th Scientific Sessions showed that adults living with type 2 diabetes participating...

ABT : 93.37 (+3.18%)
New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

ABBOTT PARK, Ill. , June 6, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare leader, announced new data revealing diabetic ketoacidosis (DKA) remains an important, yet often undetected...

ABT : 93.37 (+3.18%)
Is Abbott Laboratories Stock Underperforming the Dow?

Abbott Laboratories has trailed the Dow Jones Industrial Average over the past year, but analysts remain highly optimistic about the company's long-term growth prospects.

ABT : 93.37 (+3.18%)
BSX : 44.22 (-0.54%)
$DOWI : 51,928.44 (+0.15%)
3 Ultra-Reliable Dividend Kings Trading at Bargain-Basement Prices

These beaten-down Dividend Kings, trading near their 2026 lows, offer income, rebound potential, and Wall Street-backed upside for patient investors.

ABT : 93.37 (+3.18%)
LOW : 221.91 (+0.21%)
PEP : 139.75 (-1.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures...

See More

Key Turning Points

3rd Resistance Point 94.79
2nd Resistance Point 93.86
1st Resistance Point 92.17
Last Price 93.37
1st Support Level 89.55
2nd Support Level 88.62
3rd Support Level 86.93

See More

52-Week High 137.54
Fibonacci 61.8% 116.31
Fibonacci 50% 109.75
Fibonacci 38.2% 103.20
Last Price 93.37
52-Week Low 81.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.